ADVFN - ニュース

S&P 500

5,277.51

0.80%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	19 : 45	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KGEI	Kolibri Global Energy Inc
2024/06/03	19 : 45	Business Wire	Lindsay Announces Irrigation Project Valued at More Than $100 Million	NYSE:LNN	Lindsay Corporation
2024/06/03	19 : 45	Business Wire	The Estée Lauder Companies Completes Acquisition of DECIEM	NYSE:EL	Estee Lauder Companies Inc
2024/06/03	19 : 45	Business Wire	Kolibri Global Energy Inc. Announces Nickel Hill Production Rates and Inclusion in Russell Index	TSX:KEI	Kolibri Global Energy Inc
2024/06/03	19 : 45	Business Wire	Ferguson plc ("Company"): Total Voting Rights	NYSE:FERG	Ferguson Plc
2024/06/03	19 : 45	Business Wire	Kolibri Global Energy Inc. Announces Nickel Hill Production Rates and Inclusion in Russell Index	NASDAQ:KGEI	Kolibri Global Energy Inc
2024/06/03	19 : 45	Business Wire	Ward Dickson Appointed to Avery Dennison Board of Directors	NYSE:AVY	Avery Dennison Corp
2024/06/03	19 : 45	Business Wire	Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo	NYSE:TAK	Takeda Pharmaceutical Company Ltd
2024/06/03	19 : 45	PR Newswire (US)	Mitchell Humphrey & Co. Exhibits at the 2024 BOAF Annual Conference & Expo in Orlando, FL
2024/06/03	19 : 44	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:BPAQF	BP Plc (PK)
2024/06/03	19 : 41	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NYSE:HASI	Hannon Armstrong Sustainable Infrastructure Capital Inc
2024/06/03	19 : 39	PR Newswire (US)	SHEIN Launches SHEIN Exchange Resale Platform in Europe and the United Kingdom
2024/06/03	19 : 38	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:EW	Edwards Lifesciences Corp
2024/06/03	19 : 37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:NRSCF	Nomura Holdings Inc (PK)
2024/06/03	19 : 37	Alliance News	Springfield Properties to partner with Barratt to develop Durieshill	LSE:SPR	Springfield Properties Plc
2024/06/03	19 : 37	PR Newswire (US)	Nereus Finance Integrates LI.FI To Enable Seamless Onboarding
2024/06/03	19 : 36	NEWSBTC	Notcoin Unstoppable! Token Soars Over 400%, Blazes New All-Time High	COIN:TRXUSD	TRON
2024/06/03	19 : 36	NEWSBTC	Notcoin Unstoppable! Token Soars Over 400%, Blazes New All-Time High	COIN:ETHUSD	Ethereum
2024/06/03	19 : 36	NEWSBTC	Notcoin Unstoppable! Token Soars Over 400%, Blazes New All-Time High	COIN:FOURRUSD	Four
2024/06/03	19 : 35	GlobeNewswire Inc.	Transactions in connection with share buyback programme
2024/06/03	19 : 35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AZN	AstraZeneca PLC
2024/06/03	19 : 34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:IHG	InterContinental Hotels Group Plc
2024/06/03	19 : 34	Business Wire	DefiniGEN and Atelerix Collaborate to Ship In Vitro Cell Models Internationally Without the Need for Freezing or Cryopreservation
2024/06/03	19 : 33	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:BDX	Becton Dickinson and Company
2024/06/03	19 : 33	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:LXFR	Luxfer Holdings PLC
2024/06/03	19 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:MLCO	Melco Resorts and Entertainment Ltd
2024/06/03	19 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:POLA	Polar Power Inc
2024/06/03	19 : 30	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:TSLA	Tesla Inc
2024/06/03	19 : 30	Business Wire	Edwards Lifesciences to Sell Critical Care to BD	NYSE:EW	Edwards Lifesciences Corp
2024/06/03	19 : 30	GlobeNewswire Inc.	Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia	NASDAQ:AGIO	Agios Pharmaceuticals Inc